Bank of Montreal
RVMD icon

Bank of Montreal’s Revolution Medicines RVMD Stock Holding History

Bank of Montreal’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-63,900
Closed -$1.32K – 4240
2022
Q3 		$1.32K Buy
63,900
+16,900
+36% +$371K ﹤0.01% 2027
2022
Q2 		$896 Buy
+47,000
New +$915K ﹤0.01% 2374

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of Montreal's RVMD Position: Q2 2026 in Review

Bank of Montreal reduced its Revolution Medicines (RVMD) stake by 0.68% in Q2 2026, selling an estimated $23.2K and leaving 23,103 shares worth $4.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1429.

Bank of Montreal first reported a position in RVMD in Q2 2020 and has held it in 10 quarters since. 371 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Bank of Montreal held 23,103 shares of Revolution Medicines worth $4.33M as of Q2 2026.
  • Bank of Montreal sold 159 Revolution Medicines shares in Q2 2026, an estimated $23.2K.
  • Revolution Medicines made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1429 holding.
  • Bank of Montreal first reported a position in Revolution Medicines in Q2 2020 and has held it in 10 quarters since.
  • 371 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.